With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and minimizing disease burden, artificial organs have been playing a crucial role in enhancing patient's quality of life. Additionally, artificial organs are not only enhancing patient outcomes and accelerating recovery times, but also minimizing overall healthcare expenditure. However, only few implantable devices have been approved for clinical use, while several others are still in clinical trials awaiting approvals.

With increasing number of patients suffering from late-stage diseases, organ failure has been accounting for the largest chunk of worldwide medical spending. On the other hand, the rising success rate of transplantation has been dramatically fuelling organ failure patients to opt for artificial organs. However, as organ recipients continue to rise, patient population on the waiting list is also expanding. The imbalance between number of receivers and donor organs has compelled the healthcare sector to search for other alternatives.

These and other market data and trends are presented in "Artificial Organs: Worldwide Market Challenges & Opportunities" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

1.Methodology
- Study Reliability and Reporting Limitations
- Disclaimers
- Quantitative Techniques & Reporting Level
2.Industry Overview
- Artificial Organs Revolutionize Medical Technology Industry
- Current and Future Analysis
- Market Outlook
- Opportunities Abound for Bioartificial Organs
- Bionics to Play Crucial Role
- Economic Situation Plays A Pivotal Role in Esrd Treatment Accessibility
- Growth Drivers
- Growth Inhibitors
3.Market Trends and Issues
- Higher Development Costs and Lengthy Regulatory Process - Stumbling Blocks- for Product Commercialization
- Lack of Requisite Expertise - Hindering Implantation Process
- Alliances to Play A Key Role
- Aging Population - A Boosting Factor
- Anemia - A Growing Concern among Renal Failure Patients
- Swelling Esrd Patient Population Spurs Dialyzers Growth
- Growing Need for Efficient Control and Easy Usage
- Expiry of Warranty Provides New Opportunities
- Xenotransplantation - Other Alternative to Donor Organ Shortage
- Artificial Organs from Cloned Animal Cells - A Promising Trend
- Immunosuppressants Hold Promise in Artificial Organs Market
- Move towards Smaller Implantable Devices
- Barriers to Entry Significantly High in Dialyzers Market
- Reuse of Dialyzers - A Major Issue in Dialysis Industry
- Poor Reimbursement Environment Stymies Innovation
- Pricing Trends in Artificial Organs
4.Competitive Scenario
- Competition Heating up in Artificial Pancreas Domain
- Fresenius Medical Care - Leads The Worldwide Dialysis Equipment and Supplies- Market
- Competitive Landscape of Artificial Kidney or Dialyzers Market
- Synthetic Dialyzers to Attain Mainstay
- Asahi Kasei Medical Dominates Japanese Dialyzers Market
- Competitive Landscape of Ventricular Assist Devices
- Liver Assist Devices Competitive Landscape
5.Product Facts
- Artificial Organs
- Artificial Heart
- Artificial Kidneys
- Artificial Liver
- Artificial Pancreas
- Artificial Lungs
- Organ Rejection - A Major Barrier to Transplantation
- Other Issues for Organ Transplantation
- Combined Organ Transplantation - Gaining Attention
6.Regulatory Environment
- Regulatory Environment in The US
- Regulatory Environment in Europe
7.Corporate Developments
- Thoratec Receives Fda Approval for Heartmate Ii®
- Asahi Kasei Institutes A Sales Subsidiary in Taiwan
- Arbios Seeks Ce Marking for Sepet™
- Gambro Teams up with Debiotech for Developing Peritoneal Dialysis Cycler
- Arbios Obtains US Fda Approval for Initiating Clinical Trial for Sepet™
- Abiomed Obtains Hde Supplement Approval from Fda for Abiocor®- Implantable Artificial Heart
- Ventracor Obtains Ce Marking for Ventrassist™ Lvad
- Fresenius Medical Care Takes over Renal Solutions, Inc.
- Arbios Inks Exclusive Agreement with Nxstage for Sepet™
- Worldheart Completes First Multi-Day Animal Study of Pediaflow™ Vad
- Xcorporeal Completes Merger with Ct Holdings
- Nikkiso Collaborates with Nipro for Overseas Launch of Dialysis Systems
- Ege University to Initiate Artificial Heart Project
- Vascutek Buys Kohler Chemie's Heart Valve Business
- Novathera Partners with Novalung to Develop Advanced Artificial Lung
- Aksys Quits Kidney Dialysis Machines Business
- Twardowski Terminates License Agreement with Aksys
- Asahi Kasei Medical Fortifies Competence in Artificial Kidney Production
- Fresenius Medical Care Enhances Dialyzer Output
- Hepalife Appoints Stem Cell Systems for Bioreactor Development
- Gambro Unveils Ak 96™ Dialyzer
- Nipro Introduces Artificial Kidney Dialyzer in Overseas Markets
- University of Michigan Develops Artificial Lungs
- Usc Researchers Develop Argus Ii Retinal Prosthesis System for Retinal Implant
- Researchers Develop Cell Manipulation Technique for Organ Regeneration- Process
- Terumo to Introduce First Ce Mark Lvas in Europe
- Advanced Technique for Nerve Re-Growth Developed
8.Major Players
- Abbott Diabetes Care (USA)
- Abiomed, Inc. (USA)
- Arbios Systems, Inc. (USA)
- Asahi Kasei Kuraray Medical Co., Ltd (Japan)
- Baxter International, Inc. (USA)
- F.Hoffmann-La Roche Ltd. (Switzerland)
- Fresenius Medical Care Ag & Co. Kgaa (Germany)
- Fresenius Medical Care North America Inc (USA)
- Fresenius Kawasumi (Japan)
- Gambro Ab (Sweden)
- Hepalife Technologies, Inc. (USA)
- Jarvik Heart, Inc. (USA)
- Mc3, Inc. (USA)
- Medtronic, Inc. (USA)
- Micromed Cardiovascular, Inc. (USA)
- Nikkiso Co., Ltd. (Japan)
- Nipro Corporation (Japan)
- Syncardia Systems, Inc. (USA)
- Terumo Corporation (Japan)
- Thoratec Corporation (USA)
- Toray Medical Co., Ltd. (Japan)
- Ventracor Limited (Australia)
- Vital Therapies, Inc. (USA)
- Worldheart Corporation (USA)
9.Global Market Analytics
- Table 1: Percentage Breakdown of Leading Players in The Worldwide Dialysis Equipment and Supplies Market by Sales-
- Table 2: Percentage Breakdown of Leading Players in The Worldwide Hemodialysis Equipment and Supplies Market by Sales -
- Table 3: Percentage Breakdown of Leading Players in The Worldwide Peritoneal Dialysis Equipment and Supplies Market by Sales -
- Table 4: Percentage Breakdown of Leading Players in The Worldwide Dialyzers Market by Unit Output -
- Table 5: Percentage Breakdown of Leading Players in The Japanese Kidney Dialyzers Market by Sales -
- Table 6: Percentage Breakdown of Leading Players in The Worldwide Vads Market by Sales -
- Table 7: Global Artificial Organs Market by Product Segment for The Period 2007-2015 (Sales in US$ Million)
- Table 8: Percentage Breakdown of Global Artificial Organs Market by Product Segment for The Years 2008 &
- Table 9: Global Artificial Kidneys/Dialyzers Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 10: Percentage Breakdown of Global Artificial Kidneys/Dialyzers Market by Region for The Years 2008 &
- Table 11: Global Insulin Pumps (External) Market by Region for The Period 2007-2015 (Sales in US$ Million)
- Table 12: Percentage Breakdown of Global Insulin Pumps (External) Market by Region for The Years 2008 &
Companies Profiled

Pharmaceutical Market Research

Artificial Organs

Artificial Organs

Contents

Related products